Proteomics International is both a drug discovery company and contract service provider, focused on sophisticated analysis for the biological research market.
Proteomics International operates in three synergistic business units: Diagnostics (biomarker discovery), Therapeutics (drug discovery of peptide medicines) and Analytics (Biosimilars CRO). The company, established in 2001 and based in Perth, provides services to groups throughout the Indo-Asian region, with offices in India, Singapore, Malaysia, Japan and Hong Kong, and was the world’s first provider of proteomics services to be accredited to ISO/IEC 17025 laboratory standard.
Email: firstname.lastname@example.org | Website: www.proteomics.com.au
Bioplatforms Australia+61 0410 538 648